Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

about

Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

Item

http://www.wikidata.org/entity/Q39013336

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

@en

Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

@nl

type

Item

label

Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

@en

Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

@nl

prefLabel

Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

@en

Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

@nl

P1476

Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

@en

P2093

Rathan M Subramaniam

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

The causes and consequences of genetic heterogeneity in cancer evolution

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.

177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

The preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients.

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CPET.2016.08.010

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27863561

http://www.w3.org/2001/XMLSchema#string

P932

5134890

http://www.w3.org/2001/XMLSchema#string